1. Home
  2. IART vs NVAX Comparison

IART vs NVAX Comparison

Compare IART & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IART
  • NVAX
  • Stock Information
  • Founded
  • IART 1989
  • NVAX 1987
  • Country
  • IART United States
  • NVAX United States
  • Employees
  • IART N/A
  • NVAX N/A
  • Industry
  • IART Medical/Dental Instruments
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IART Health Care
  • NVAX Health Care
  • Exchange
  • IART Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • IART 1.8B
  • NVAX 2.0B
  • IPO Year
  • IART 1995
  • NVAX 1995
  • Fundamental
  • Price
  • IART $22.87
  • NVAX $9.00
  • Analyst Decision
  • IART Hold
  • NVAX Buy
  • Analyst Count
  • IART 8
  • NVAX 6
  • Target Price
  • IART $28.14
  • NVAX $17.83
  • AVG Volume (30 Days)
  • IART 632.1K
  • NVAX 3.6M
  • Earning Date
  • IART 11-04-2024
  • NVAX 11-12-2024
  • Dividend Yield
  • IART N/A
  • NVAX N/A
  • EPS Growth
  • IART N/A
  • NVAX N/A
  • EPS
  • IART N/A
  • NVAX N/A
  • Revenue
  • IART $1,564,920,000.00
  • NVAX $885,193,000.00
  • Revenue This Year
  • IART $6.71
  • NVAX N/A
  • Revenue Next Year
  • IART $6.08
  • NVAX N/A
  • P/E Ratio
  • IART N/A
  • NVAX N/A
  • Revenue Growth
  • IART 1.45
  • NVAX N/A
  • 52 Week Low
  • IART $16.81
  • NVAX $3.53
  • 52 Week High
  • IART $45.42
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • IART 47.04
  • NVAX 49.30
  • Support Level
  • IART $22.87
  • NVAX $8.13
  • Resistance Level
  • IART $24.59
  • NVAX $9.75
  • Average True Range (ATR)
  • IART 0.70
  • NVAX 0.46
  • MACD
  • IART -0.25
  • NVAX 0.12
  • Stochastic Oscillator
  • IART 13.74
  • NVAX 48.15

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: